Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

WIN Symposium 2015 highlights

Prof Richard Schilsky - Chief Medical Officer of the American Society of Oncology (ASCO)
WIN Symposium 2015 highlights ( Prof Richard Schilsky - Chief Medical Officer of the American Society of Oncology (ASCO) )
6 Jul 2015

Next generation of trials with targeted agents

Prof Richard Schilsky - Chief Medical Officer of the American Society of Oncology (ASCO)
Next generation of trials with targeted agents ( Prof Richard Schilsky - Chief Medical Officer of the American Society of Oncology (ASCO) )
6 Jul 2015

Taking biopsies in clinical trials: The WINTHER laboratory experience

Dr Paolo Nuciforo - Vall d'Hebron Institute of Oncology, Barcelona, Spain
Taking biopsies in clinical trials: The WINTHER laboratory experience ( Dr Paolo Nuciforo - Vall d'Hebron Institute of Oncology, Barcelona, Spain )
6 Jul 2015

Meta-analysis confirms benefits and safety of precision medicine

Prof Razelle Kurzrock - University of California, San Diego, USA
Meta-analysis confirms benefits and safety of precision medicine ( Prof Razelle Kurzrock - University of California, San Diego, USA )
3 Jul 2015

SPECTAlung: improving clinical trial access for patients with thoracic tumours

Dr Jessica Menis and Dr Benjamin Besse
SPECTAlung: improving clinical trial access for patients with thoracic tumours ( Dr Jessica Menis and Dr Benjamin Besse )
3 Jul 2015

Chemoresistance and residual disease promoted by DNMT3A R882 in AML

Dr Olga Guryanova - Memorial Sloan Kettering Cancer Center, New York, USA
Chemoresistance and residual disease promoted by DNMT3A R882 in AML ( Dr Olga Guryanova - Memorial Sloan Kettering Cancer Center, New York, USA )
19 Jun 2015

Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma

Dr Jessica Okosun - Barts Cancer Institute, London, UK
Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma ( Dr Jessica Okosun - Barts Cancer Institute, London, UK )
16 Jun 2015

Exciting update on the Repurposing Drugs in Oncology (ReDO) project

Dr Gauthier Bouche - Anticancer Fund, Strombeek-Bever, Belgium
Exciting update on the Repurposing Drugs in Oncology (ReDO) project ( Dr Gauthier Bouche - Anticancer Fund, Strombeek-Bever, Belgium )
15 Jun 2015

EHA 2015: Expert opinions on new treatment standard in multiple myeloma

Prof Pieter Sonneveld, Prof Antonio Palumbo, Prof Gordon McVie, Prof Thierry Facon
EHA 2015: Expert opinions on new treatment standard in multiple myeloma ( Prof Pieter Sonneveld, Prof Antonio Palumbo, Prof Gordon McVie, Prof Thierry Facon )
13 Jun 2015

Genomic sequencing to find AML-causing mutations

Dr George Vassiliou - Cambridge Cancer Centre, Cambridge, UK
Genomic sequencing to find AML-causing mutations ( Dr George Vassiliou - Cambridge Cancer Centre, Cambridge, UK )
13 Jun 2015

Measuring molecular responses to tyrosine kinase inhibitors in chronic myeloid leukaemia

Prof Susan Branford - Adelaide University Adelaide, Australia
Measuring molecular responses to tyrosine kinase inhibitors in chronic myeloid leukaemia ( Prof Susan Branford - Adelaide University Adelaide, Australia )
13 Jun 2015

Advances in the treatment and management of CLL

Prof Clemens Wendtner and Prof Peter Hillmen
Advances in the treatment and management of CLL ( Prof Clemens Wendtner and Prof Peter Hillmen )
13 Jun 2015